Enzyme Models—From Catalysis to Prodrugs

Z Breijyeh, R Karaman - Molecules, 2021 - mdpi.com
… This article describes the works done on enzyme models and the computational … of Kirbys
enzyme models were used to design simvastatin prodrugs (Figure 7) by linking the statin-free …

[PDF][PDF] Synthesis, Characterization, and In Vitro Conversion Kinetics of Novel Atorvastatin Prodrugs

BA Al-Jubeh - 2022 - dspace.alquds.edu
statins, or substitute for patients who are intolerant to statins, … In the era of advanced
technology, various computational … on proton transfers in Kirbys enzyme model by linking the free …

Newly developed prodrugs and prodrugs in development; an insight of the recent years

A Najjar, A Najjar, R Karaman - Molecules, 2020 - mdpi.com
… were investigating the effects of statins in combination or as … gained without the use of
computational data. However, to … Bruice’s cyclization of dicarboxylic semiesters and Kirbys acid-…

[PDF][PDF] Deanship of Graduate Studies Al-Quds University

HAA Sinokrot - dspace.alquds.edu
enzyme models were utilized in my prodrug design approach which was accomplished using
computational calculations based … [73, 79, 80] and statins for treatment of high cholesterol …

[PDF][PDF] Design of Bitterless Atenolol Prodrugs for the Use in Aqueous Formulations for Pediatrics and Geriatrics

R Karaman, A Qtait - 2021 - researchgate.net
… and kinetic studies described in this paper is based on intramolecular process using molecular
Computationally designed prodrugs of statins based on Kirbys enzyme model. Journal of …

[PDF][PDF] Drug delivery approaches

W Amly, R Karaman - Modern Adv Pharm Res, 2019 - researchgate.net
… Analyzing the efficiency of proton transfer to carbon in Kirbys enzyme model: A computational
Computationally designed prodrugs of statins based on Kirby's enzyme model. J Mol …

Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy

B Bechtold, J Clarke - Expert opinion on drug metabolism & …, 2021 - Taylor & Francis
… However, the model continued to under-predict the statinis SN-38, the active anti-cancer
metabolite of the prodrug … in transporters and metabolizing enzymes is a significant limitation …

Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor

…, DG Wolford, A Xu, T Zhao, D Zhou, S Zhou… - Circulation, 2023 - Am Heart Assoc
… intervention were limited to proteins like enzymes, G-protein coupled … statin-treated participants
following a single oral dose of MK-0616 (-001) or of plasma LDL-C from baseline in statin-…

Targeting Metalloenzymes: The “Achilles' Heel” of Viruses and Parasites

D Moianos, GM Prifti, M Makri, G Zoidis - Pharmaceuticals, 2023 - mdpi.com
… potent in enzymatic PA N assays, showcasing the models … issue, probably through prodrug
formulations—following the … proven by enzymatic experiments and computational theoretical …

Evaluation for Potential Drug–Drug Interaction of MT921 Using In Vitro Studies and Physiologically–Based Pharmacokinetic Models

H Ryu, H Moon, J Lee, G Yang, S Yang, H Yun… - Pharmaceuticals, 2021 - mdpi.com
developed [30,31,32] to investigate bile recirculation and AMLO DDI prediction with other
drugs. Therefore, we first developed a model … to implement these metabolizing enzymes, total …